[GENTING] YoY Cumulative Quarter Result on 31-Dec-2020 [#4]

Announcement Date
25-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 2.38%
YoY- -151.31%
View:
Show?
Cumulative Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 27,118,560 22,383,714 13,529,534 11,564,060 21,616,543 20,852,973 20,019,594 5.18%
PBT 3,567,037 1,265,064 -970,782 -1,526,452 4,582,582 3,418,398 4,312,215 -3.11%
Tax -1,299,805 -1,220,643 -442,305 -547,525 -901,487 -974,529 -1,069,360 3.30%
NP 2,267,232 44,421 -1,413,087 -2,073,977 3,681,095 2,443,869 3,242,855 -5.78%
-
NP to SH 929,201 -299,909 -1,369,646 -1,024,141 1,995,823 1,365,581 1,445,298 -7.09%
-
Tax Rate 36.44% 96.49% - - 19.67% 28.51% 24.80% -
Total Cost 24,851,328 22,339,293 14,942,621 13,638,037 17,935,448 18,409,104 16,776,739 6.76%
-
Net Worth 33,692,750 31,690,436 31,805,956 32,961,137 35,348,509 34,270,338 33,777,124 -0.04%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 577,590 616,096 423,566 577,590 847,132 827,879 822,432 -5.71%
Div Payout % 62.16% 0.00% 0.00% 0.00% 42.45% 60.62% 56.90% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 33,692,750 31,690,436 31,805,956 32,961,137 35,348,509 34,270,338 33,777,124 -0.04%
NOSH 3,876,896 3,876,896 3,876,896 3,876,896 3,876,896 3,876,896 3,851,782 0.10%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 8.36% 0.20% -10.44% -17.93% 17.03% 11.72% 16.20% -
ROE 2.76% -0.95% -4.31% -3.11% 5.65% 3.98% 4.28% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 704.27 581.30 351.36 300.32 561.38 541.55 523.35 5.07%
EPS 24.13 -7.79 -35.57 -26.60 51.83 35.58 38.28 -7.39%
DPS 15.00 16.00 11.00 15.00 22.00 21.50 21.50 -5.82%
NAPS 8.75 8.23 8.26 8.56 9.18 8.90 8.83 -0.15%
Adjusted Per Share Value based on latest NOSH - 3,876,896
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 699.49 577.36 348.98 298.28 557.57 537.88 516.38 5.18%
EPS 23.97 -7.74 -35.33 -26.42 51.48 35.22 37.28 -7.09%
DPS 14.90 15.89 10.93 14.90 21.85 21.35 21.21 -5.71%
NAPS 8.6907 8.1742 8.204 8.5019 9.1177 8.8396 8.7124 -0.04%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 4.62 4.48 4.67 4.46 6.05 6.10 9.20 -
P/RPS 0.66 0.77 1.33 1.49 1.08 1.13 1.76 -15.07%
P/EPS 19.15 -57.52 -13.13 -16.77 11.67 17.20 24.35 -3.92%
EY 5.22 -1.74 -7.62 -5.96 8.57 5.81 4.11 4.06%
DY 3.25 3.57 2.36 3.36 3.64 3.52 2.34 5.62%
P/NAPS 0.53 0.54 0.57 0.52 0.66 0.69 1.04 -10.62%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/02/24 23/02/23 24/02/22 25/02/21 27/02/20 27/02/19 27/02/18 -
Price 4.77 4.71 4.50 4.63 5.16 7.32 8.99 -
P/RPS 0.68 0.81 1.28 1.54 0.92 1.35 1.72 -14.32%
P/EPS 19.77 -60.47 -12.65 -17.41 9.96 20.64 23.79 -3.03%
EY 5.06 -1.65 -7.90 -5.74 10.04 4.84 4.20 3.15%
DY 3.14 3.40 2.44 3.24 4.26 2.94 2.39 4.65%
P/NAPS 0.55 0.57 0.54 0.54 0.56 0.82 1.02 -9.77%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment